{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:57:12Z","timestamp":1791262632961,"version":"4.1.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Qingdao Key Clinical Specialty Elite Discipline","award":["No.Y-HR2018-185"],"award-info":[{"award-number":["No.Y-HR2018-185"]}]},{"name":"Qingdao Key Clinical Specialty Elite Discipline","award":["No.Y-HR2018-185"],"award-info":[{"award-number":["No.Y-HR2018-185"]}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"crossref","award":["No.Y2019-AZZD-0471"],"award-info":[{"award-number":["No.Y2019-AZZD-0471"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"crossref","award":["No.Y2019-AZZD-0471"],"award-info":[{"award-number":["No.Y2019-AZZD-0471"]}],"id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hum Genomics"],"DOI":"10.1186\/s40246-024-00682-w","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T03:02:57Z","timestamp":1730775777000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Development of oxidative stress- and ferroptosis-related prognostic signature in gastric cancer and identification of CDH19 as a novel biomarker"],"prefix":"10.1186","volume":"18","author":[{"given":"Shibo","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyu","family":"Leng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxue","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufen","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wensheng","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"682_CR1","doi-asserted-by":"publisher","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349. https:\/\/doi.org\/10.3322\/caac.21820.","DOI":"10.3322\/caac.21820"},{"key":"682_CR2","doi-asserted-by":"publisher","first-page":"103841","DOI":"10.1016\/j.critrevonc.2022.103841","volume":"181","author":"MJ L\u00f3pez","year":"2023","unstructured":"L\u00f3pez MJ, Carbajal J, Alfaro AL, Saravia LG, Zanabria D, Araujo JM, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2023;181:103841. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103841.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"5","key":"682_CR3","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1158\/1055-9965.Epi-13-1057","volume":"23","author":"P Karimi","year":"2014","unstructured":"Karimi P, Islami F, Anandasabapathy S, Freedman ND, Kamangar F. Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention. Cancer Epidemiol Biomarkers Prev. 2014;23(5):700\u201313. https:\/\/doi.org\/10.1158\/1055-9965.Epi-13-1057.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"682_CR4","doi-asserted-by":"publisher","unstructured":"Smyth EC, Nilsson M, Grabsch HI, van Grieken NC, Lordick F. Gastric cancer. Lancet. (2020);396(10251):635\u201348. https:\/\/doi.org\/10.1016\/s0140-6736(20)31288-5","DOI":"10.1016\/s0140-6736(20)31288-5"},{"issue":"1","key":"682_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13045-023-01451-3","volume":"16","author":"WL Guan","year":"2023","unstructured":"Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16(1):57. https:\/\/doi.org\/10.1186\/s13045-023-01451-3.","journal-title":"J Hematol Oncol"},{"issue":"4","key":"682_CR6","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22(4):266\u201382. https:\/\/doi.org\/10.1038\/s41580-020-00324-8.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"2","key":"682_CR7","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","volume":"31","author":"D Tang","year":"2021","unstructured":"Tang D, Chen X, Kang R, Kroemer G. Ferroptosis: molecular mechanisms and health implications. Cell Res. 2021;31(2):107\u201325. https:\/\/doi.org\/10.1038\/s41422-020-00441-1.","journal-title":"Cell Res"},{"issue":"12","key":"682_CR8","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"M Conrad","year":"2019","unstructured":"Conrad M, Pratt DA. The chemical basis of ferroptosis. Nat Chem Biol. 2019;15(12):1137\u201347. https:\/\/doi.org\/10.1038\/s41589-019-0408-1.","journal-title":"Nat Chem Biol"},{"key":"682_CR9","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3389\/fphar.2014.00124","volume":"5","author":"DL Zhang","year":"2014","unstructured":"Zhang DL, Ghosh MC, Rouault TA. The physiological functions of iron regulatory proteins in iron homeostasis - an update. Front Pharmacol. 2014;5:124. https:\/\/doi.org\/10.3389\/fphar.2014.00124.","journal-title":"Front Pharmacol"},{"issue":"4","key":"682_CR10","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.bbalip.2014.10.002","volume":"1851","author":"H Kuhn","year":"2015","unstructured":"Kuhn H, Banthiya S, van Leyen K. Mammalian lipoxygenases and their biological relevance. Biochim Biophys Acta. 2015;1851(4):308\u201330. https:\/\/doi.org\/10.1016\/j.bbalip.2014.10.002.","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"682_CR11","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1038\/s41589-020-0472-6","volume":"16","author":"Y Zou","year":"2020","unstructured":"Zou Y, Li H, Graham ET, Deik AA, Eaton JK, Wang W, et al. Cytochrome P450 oxidoreductase contributes to phospholipid peroxidation in ferroptosis. Nat Chem Biol. 2020;16(3):302\u20139. https:\/\/doi.org\/10.1038\/s41589-020-0472-6.","journal-title":"Nat Chem Biol"},{"key":"682_CR12","doi-asserted-by":"publisher","unstructured":"Hao X, Zheng Z, Liu H, Zhang Y, Kang J, Kong X et al. Inhibition of APOC1 promotes the transformation of M2 into M1 macrophages via the ferroptosis pathway and enhances anti-PD1 immunotherapy in hepatocellular carcinoma based on single-cell RNA sequencing. Redox Biol. (2022);56:102463. https:\/\/doi.org\/10.1016\/j.redox.2022.102463","DOI":"10.1016\/j.redox.2022.102463"},{"issue":"1","key":"682_CR13","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.cmet.2022.09.021","volume":"35","author":"F Yang","year":"2023","unstructured":"Yang F, Xiao Y, Ding JH, Jin X, Ma D, Li DQ, et al. Ferroptosis heterogeneity in triple-negative breast cancer reveals an innovative immunotherapy combination strategy. Cell Metab. 2023;35(1):84\u2013e1008. https:\/\/doi.org\/10.1016\/j.cmet.2022.09.021.","journal-title":"Cell Metab"},{"key":"682_CR14","doi-asserted-by":"publisher","unstructured":"Zou J, Wang L, Tang H, Liu X, Peng F, Peng C. Ferroptosis in Non-small Cell Lung Cancer: progression and therapeutic potential on it. Int J Mol Sci. 2021;22(24). https:\/\/doi.org\/10.3390\/ijms222413335.","DOI":"10.3390\/ijms222413335"},{"issue":"2","key":"682_CR15","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/s41556-020-0461-8","volume":"22","author":"H Lee","year":"2020","unstructured":"Lee H, Zandkarimi F, Zhang Y, Meena JK, Kim J, Zhuang L, et al. Energy-stress-mediated AMPK activation inhibits ferroptosis. Nat Cell Biol. 2020;22(2):225\u201334. https:\/\/doi.org\/10.1038\/s41556-020-0461-8.","journal-title":"Nat Cell Biol"},{"key":"682_CR16","doi-asserted-by":"publisher","unstructured":"Wu J, Minikes AM, Gao M, Bian H, Li Y, Stockwell BR et al. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling. Nature. (2019);572(7769):402\u20136. https:\/\/doi.org\/10.1038\/s41586-019-1426-6","DOI":"10.1038\/s41586-019-1426-6"},{"issue":"10","key":"682_CR17","doi-asserted-by":"publisher","first-page":"2501","DOI":"10.1016\/j.celrep.2019.07.107","volume":"28","author":"WH Yang","year":"2019","unstructured":"Yang WH, Ding CC, Sun T, Rupprecht G, Lin CC, Hsu D, et al. The Hippo Pathway Effector TAZ regulates ferroptosis in renal cell carcinoma. Cell Rep. 2019;28(10):2501\u2013e84. https:\/\/doi.org\/10.1016\/j.celrep.2019.07.107.","journal-title":"Cell Rep"},{"issue":"9","key":"682_CR18","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1038\/s41573-021-00233-1","volume":"20","author":"HJ Forman","year":"2021","unstructured":"Forman HJ, Zhang H. Targeting oxidative stress in disease: promise and limitations of antioxidant therapy. Nat Rev Drug Discov. 2021;20(9):689\u2013709. https:\/\/doi.org\/10.1038\/s41573-021-00233-1.","journal-title":"Nat Rev Drug Discov"},{"key":"682_CR19","doi-asserted-by":"publisher","unstructured":"Hayes JD, Dinkova-Kostova AT, Tew KD. Oxidative stress in Cancer. Cancer Cell. (2020);38(2):167\u201397. https:\/\/doi.org\/10.1016\/j.ccell.2020.06.001","DOI":"10.1016\/j.ccell.2020.06.001"},{"issue":"1","key":"682_CR20","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1186\/s13287-023-03571-6","volume":"14","author":"R Farahzadi","year":"2023","unstructured":"Farahzadi R, Valipour B, Fathi E, Pirmoradi S, Molavi O, Montazersaheb S, et al. Oxidative stress regulation and related metabolic pathways in epithelial-mesenchymal transition of breast cancer stem cells. Stem Cell Res Ther. 2023;14(1):342. https:\/\/doi.org\/10.1186\/s13287-023-03571-6.","journal-title":"Stem Cell Res Ther"},{"key":"682_CR21","doi-asserted-by":"publisher","unstructured":"Franchini F, Palatucci G, Colao A, Ungaro P, Macchia PE, Nettore IC. Obesity and thyroid Cancer risk: an update. Int J Environ Res Public Health. 2022;19(3). https:\/\/doi.org\/10.3390\/ijerph19031116.","DOI":"10.3390\/ijerph19031116"},{"issue":"7","key":"682_CR22","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1002\/2211-5463.13630","volume":"13","author":"Y Yu","year":"2023","unstructured":"Yu Y, Wu Y, Zhang Y, Lu M, Su X. Oxidative stress in the tumor microenvironment in gastric cancer and its potential role in immunotherapy. FEBS Open Bio. 2023;13(7):1238\u201352. https:\/\/doi.org\/10.1002\/2211-5463.13630.","journal-title":"FEBS Open Bio"},{"issue":"12","key":"682_CR23","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1038\/nrd4002","volume":"12","author":"C Gorrini","year":"2013","unstructured":"Gorrini C, Harris IS, Mak TW. Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov. 2013;12(12):931\u201347. https:\/\/doi.org\/10.1038\/nrd4002.","journal-title":"Nat Rev Drug Discov"},{"issue":"D1","key":"682_CR24","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","author":"The Gene Ontology Resource","year":"2019","unstructured":"The Gene Ontology Resource. 20 years and still GOing strong. Nucleic Acids Res. 2019;47(D1):D330\u20138. https:\/\/doi.org\/10.1093\/nar\/gky1055.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"682_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27.","journal-title":"Nucleic Acids Res"},{"key":"682_CR26","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1186\/1471-2105-14-244","volume":"14","author":"H Zhang","year":"2013","unstructured":"Zhang H, Meltzer P, Davis S. RCircos: an R package for Circos 2D track plots. BMC Bioinformatics. 2013;14:244. https:\/\/doi.org\/10.1186\/1471-2105-14-244.","journal-title":"BMC Bioinformatics"},{"issue":"7","key":"682_CR27","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47. https:\/\/doi.org\/10.1093\/nar\/gkv007.","journal-title":"Nucleic Acids Res"},{"key":"682_CR28","doi-asserted-by":"publisher","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133. https:\/\/doi.org\/10.1093\/bioinformatics\/btq170.","DOI":"10.1093\/bioinformatics\/btq170"},{"key":"682_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7. https:\/\/doi.org\/10.1186\/1471-2105-14-7.","journal-title":"BMC Bioinformatics"},{"key":"682_CR30","doi-asserted-by":"publisher","unstructured":"Daniel D, West-Mitchell K. The Sankey diagram: an exploratory application of a data visualization tool. Transfusion. (2024). https:\/\/doi.org\/10.1111\/trf.17803","DOI":"10.1111\/trf.17803"},{"issue":"4","key":"682_CR31","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/s1470-2045(14)71116-7","volume":"16","author":"VP Balachandran","year":"2015","unstructured":"Balachandran VP, Gonen M, Smith JJ, DeMatteo RP. Nomograms in oncology: more than meets the eye. Lancet Oncol. 2015;16(4):e173\u201380. https:\/\/doi.org\/10.1016\/s1470-2045(14)71116-7.","journal-title":"Lancet Oncol"},{"issue":"7","key":"682_CR32","doi-asserted-by":"publisher","first-page":"07tr1","DOI":"10.1088\/1361-6560\/aab4b1","volume":"63","author":"NA Obuchowski","year":"2018","unstructured":"Obuchowski NA, Bullen JA. Receiver operating characteristic (ROC) curves: review of methods with applications in diagnostic medicine. Phys Med Biol. 2018;63(7):07tr1. https:\/\/doi.org\/10.1088\/1361-6560\/aab4b1.","journal-title":"Phys Med Biol"},{"key":"682_CR33","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","volume":"4","author":"K Yoshihara","year":"2013","unstructured":"Yoshihara K, Shahmoradgoli M, Mart\u00ednez E, Vegesna R, Kim H, Torres-Garcia W, et al. Inferring tumour purity and stromal and immune cell admixture from expression data. Nat Commun. 2013;4:2612. https:\/\/doi.org\/10.1038\/ncomms3612.","journal-title":"Nat Commun"},{"key":"682_CR34","doi-asserted-by":"publisher","first-page":"1245514","DOI":"10.3389\/fimmu.2023.1245514","volume":"14","author":"F Zhao","year":"2023","unstructured":"Zhao F, Zhao C, Xu T, Lan Y, Lin H, Wu X, et al. Single-cell and bulk RNA sequencing analysis of B cell marker genes in TNBC TME landscape and immunotherapy. Front Immunol. 2023;14:1245514. https:\/\/doi.org\/10.3389\/fimmu.2023.1245514.","journal-title":"Front Immunol"},{"key":"682_CR35","doi-asserted-by":"publisher","first-page":"682002","DOI":"10.3389\/fcell.2021.682002","volume":"9","author":"TT Liu","year":"2021","unstructured":"Liu TT, Li R, Huo C, Li JP, Yao J, Ji XL, et al. Identification of CDK2-Related Immune Forecast Model and ceRNA in Lung Adenocarcinoma, a Pan-cancer Analysis. Front Cell Dev Biol. 2021;9:682002. https:\/\/doi.org\/10.3389\/fcell.2021.682002.","journal-title":"Front Cell Dev Biol"},{"key":"682_CR36","doi-asserted-by":"publisher","unstructured":"Maeser D, Gruener RF, Huang RS. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data. Brief Bioinform. 2021;22(6). https:\/\/doi.org\/10.1093\/bib\/bbab260.","DOI":"10.1093\/bib\/bbab260"},{"issue":"3","key":"682_CR37","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1038\/s41573-018-0006-z","volume":"18","author":"RS Riley","year":"2019","unstructured":"Riley RS, June CH, Langer R, Mitchell MJ. Delivery technologies for cancer immunotherapy. Nat Rev Drug Discov. 2019;18(3):175\u201396. https:\/\/doi.org\/10.1038\/s41573-018-0006-z.","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"682_CR38","doi-asserted-by":"publisher","first-page":"1342","DOI":"10.1038\/nm.4191","volume":"22","author":"RJ Hause","year":"2016","unstructured":"Hause RJ, Pritchard CC, Shendure J, Salipante SJ. Classification and characterization of microsatellite instability across 18 cancer types. Nat Med. 2016;22(11):1342\u201350. https:\/\/doi.org\/10.1038\/nm.4191.","journal-title":"Nat Med"},{"issue":"1","key":"682_CR39","doi-asserted-by":"publisher","first-page":"117","DOI":"10.21147\/j.issn.1000-9604.2019.01.07","volume":"31","author":"T Diagnosis","year":"2019","unstructured":"Diagnosis T, Guidelines For Colorectal Cancer Working Group C. Chinese Society of Clinical Oncology (CSCO) diagnosis and treatment guidelines for colorectal cancer 2018 (English version). Chin J Cancer Res. 2019;31(1):117\u201334. https:\/\/doi.org\/10.21147\/j.issn.1000-9604.2019.01.07.","journal-title":"Chin J Cancer Res"},{"issue":"3","key":"682_CR40","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1200\/jco.2005.01.086","volume":"23","author":"S Popat","year":"2005","unstructured":"Popat S, Hubner R, Houlston RS. Systematic review of microsatellite instability and colorectal cancer prognosis. J Clin Oncol. 2005;23(3):609\u201318. https:\/\/doi.org\/10.1200\/jco.2005.01.086.","journal-title":"J Clin Oncol"},{"key":"682_CR41","doi-asserted-by":"publisher","unstructured":"Choi YY, Kim H, Shin SJ, Kim HY, Lee J, Yang HK et al. Microsatellite instability and Programmed Cell Death-Ligand 1 expression in stage II\/III gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized controlled study. Ann Surg. (2019);270(2):309\u201316. https:\/\/doi.org\/10.1097\/sla.0000000000002803","DOI":"10.1097\/sla.0000000000002803"},{"issue":"6349","key":"682_CR42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1126\/science.aan6733","volume":"357","author":"DT Le","year":"2017","unstructured":"Le DT, Durham JN, Smith KN, Wang H, Bartlett BR, Aulakh LK, et al. Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade. Science. 2017;357(6349):409\u201313. https:\/\/doi.org\/10.1126\/science.aan6733.","journal-title":"Science"},{"key":"682_CR43","doi-asserted-by":"publisher","first-page":"103374","DOI":"10.1016\/j.critrevonc.2021.103374","volume":"163","author":"A Addeo","year":"2021","unstructured":"Addeo A, Friedlaender A, Banna GL, Weiss GJ. TMB or not TMB as a biomarker: that is the question. Crit Rev Oncol Hematol. 2021;163:103374. https:\/\/doi.org\/10.1016\/j.critrevonc.2021.103374.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"682_CR44","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1038\/s41392-022-01004-z","volume":"7","author":"B Gan","year":"2022","unstructured":"Gan B. ACSL4, PUFA, and ferroptosis: new arsenal in anti-tumor immunity. Signal Transduct Target Ther. 2022;7(1):128. https:\/\/doi.org\/10.1038\/s41392-022-01004-z.","journal-title":"Signal Transduct Target Ther"},{"issue":"7","key":"682_CR45","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41568-022-00459-0","volume":"22","author":"G Lei","year":"2022","unstructured":"Lei G, Zhuang L, Gan B. Targeting ferroptosis as a vulnerability in cancer. Nat Rev Cancer. 2022;22(7):381\u201396. https:\/\/doi.org\/10.1038\/s41568-022-00459-0.","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"682_CR46","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1080\/15548627.2020.1810918","volume":"17","author":"X Chen","year":"2021","unstructured":"Chen X, Li J, Kang R, Klionsky DJ, Tang D. Ferroptosis: machinery and regulation. Autophagy. 2021;17(9):2054\u201381. https:\/\/doi.org\/10.1080\/15548627.2020.1810918.","journal-title":"Autophagy"},{"issue":"5","key":"682_CR47","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","volume":"18","author":"X Chen","year":"2021","unstructured":"Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18(5):280\u201396. https:\/\/doi.org\/10.1038\/s41571-020-00462-0.","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"682_CR48","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/cac2.12250","volume":"42","author":"L Zhao","year":"2022","unstructured":"Zhao L, Zhou X, Xie F, Zhang L, Yan H, Huang J, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond). 2022;42(2):88\u2013116. https:\/\/doi.org\/10.1002\/cac2.12250.","journal-title":"Cancer Commun (Lond)"},{"issue":"49","key":"682_CR49","doi-asserted-by":"publisher","first-page":"31189","DOI":"10.1073\/pnas.2017152117","volume":"117","author":"J Yi","year":"2020","unstructured":"Yi J, Zhu J, Wu J, Thompson CB, Jiang X. Oncogenic activation of PI3K-AKT-mTOR signaling suppresses ferroptosis via SREBP-mediated lipogenesis. Proc Natl Acad Sci U S A. 2020;117(49):31189\u201397. https:\/\/doi.org\/10.1073\/pnas.2017152117.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"682_CR50","doi-asserted-by":"publisher","first-page":"102317","DOI":"10.1016\/j.redox.2022.102317","volume":"52","author":"S Ouyang","year":"2022","unstructured":"Ouyang S, Li H, Lou L, Huang Q, Zhang Z, Mo J, et al. Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol. 2022;52:102317. https:\/\/doi.org\/10.1016\/j.redox.2022.102317.","journal-title":"Redox Biol"},{"key":"682_CR51","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753. https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107753.","journal-title":"Pharmacol Ther"},{"issue":"Pt 3","key":"682_CR52","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/j.semcancer.2022.03.009","volume":"86","author":"X Niu","year":"2022","unstructured":"Niu X, Chen L, Li Y, Hu Z, He F. Ferroptosis, necroptosis, and pyroptosis in the tumor microenvironment: perspectives for immunotherapy of SCLC. Semin Cancer Biol. 2022;86(Pt 3):273\u201385. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.009.","journal-title":"Semin Cancer Biol"},{"issue":"10","key":"682_CR53","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski TF, Schreiber H, Fu YX. Innate and adaptive immune cells in the tumor microenvironment. Nat Immunol. 2013;14(10):1014\u201322. https:\/\/doi.org\/10.1038\/ni.2703.","journal-title":"Nat Immunol"},{"issue":"8","key":"682_CR54","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1002\/eji.201847659","volume":"49","author":"A Tanaka","year":"2019","unstructured":"Tanaka A, Sakaguchi S. Targeting Treg cells in cancer immunotherapy. Eur J Immunol. 2019;49(8):1140\u20136. https:\/\/doi.org\/10.1002\/eji.201847659.","journal-title":"Eur J Immunol"},{"key":"682_CR55","doi-asserted-by":"publisher","unstructured":"Ku SC, Liu HL, Su CY, Yeh IJ, Yen MC, Anuraga G et al. Comprehensive analysis of prognostic significance of cadherin (CDH) gene family in breast cancer. Aging (Albany NY). (2022);14(20):8498\u2013567. https:\/\/doi.org\/10.18632\/aging.204357","DOI":"10.18632\/aging.204357"},{"key":"682_CR56","doi-asserted-by":"publisher","first-page":"989","DOI":"10.3389\/fonc.2019.00989","volume":"9","author":"W Yu","year":"2019","unstructured":"Yu W, Yang L, Li T, Zhang Y. Cadherin signaling in Cancer: its functions and role as a therapeutic target. Front Oncol. 2019;9:989. https:\/\/doi.org\/10.3389\/fonc.2019.00989.","journal-title":"Front Oncol"},{"key":"682_CR57","doi-asserted-by":"publisher","first-page":"1137013","DOI":"10.3389\/fcell.2023.1137013","volume":"11","author":"WH Lin","year":"2023","unstructured":"Lin WH, Cooper LM, Anastasiadis PZ. Cadherins and catenins in cancer: connecting cancer pathways and tumor microenvironment. Front Cell Dev Biol. 2023;11:1137013. https:\/\/doi.org\/10.3389\/fcell.2023.1137013.","journal-title":"Front Cell Dev Biol"},{"key":"682_CR58","doi-asserted-by":"publisher","unstructured":"Minikes AM, Song Y, Feng Y, Yoon C, Yoon SS, Jiang X. E-cadherin is a biomarker for ferroptosis sensitivity in diffuse gastric cancer. Oncogene. 2023;42(11):848\u201357. https:\/\/doi.org\/10.1038\/s41388-023-02599-5.","DOI":"10.1038\/s41388-023-02599-5"},{"issue":"1","key":"682_CR59","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1080\/15548627.2022.2059170","volume":"19","author":"X Chen","year":"2023","unstructured":"Chen X, Song X, Li J, Zhang R, Yu C, Zhou Z, et al. Identification of HPCAL1 as a specific autophagy receptor involved in ferroptosis. Autophagy. 2023;19(1):54\u201374. https:\/\/doi.org\/10.1080\/15548627.2022.2059170.","journal-title":"Autophagy"},{"issue":"1","key":"682_CR60","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1186\/s12903-023-03046-3","volume":"23","author":"J Xie","year":"2023","unstructured":"Xie J, Lan T, Zheng DL, Ding LC, Lu YG. CDH4 inhibits ferroptosis in oral squamous cell carcinoma cells. BMC Oral Health. 2023;23(1):329. https:\/\/doi.org\/10.1186\/s12903-023-03046-3.","journal-title":"BMC Oral Health"},{"issue":"4","key":"682_CR61","doi-asserted-by":"publisher","first-page":"955","DOI":"10.18388\/abp.2020_6902","volume":"70","author":"J Yu","year":"2023","unstructured":"Yu J, Sun X, Yu Y, Cui X. The cadherin protein CDH19 mediates cervical carcinoma progression by regulating AKT\/NF-\u03baB signaling. Acta Biochim Pol. 2023;70(4):955\u201361. https:\/\/doi.org\/10.18388\/abp.2020_6902.","journal-title":"Acta Biochim Pol"},{"issue":"1","key":"682_CR62","doi-asserted-by":"publisher","first-page":"2782","DOI":"10.1038\/s41598-024-53265-z","volume":"14","author":"H Wang","year":"2024","unstructured":"Wang H, Liu J, Lou Y, Liu Y, Chen J, Liao X, et al. Identification and preliminary analysis of hub genes associated with bladder cancer progression by comprehensive bioinformatics analysis. Sci Rep. 2024;14(1):2782. https:\/\/doi.org\/10.1038\/s41598-024-53265-z.","journal-title":"Sci Rep"},{"issue":"15","key":"682_CR63","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.21037\/atm-21-2934","volume":"9","author":"Y Shi","year":"2021","unstructured":"Shi Y, Han T, Liu C. CircRNA hsa_circ_0006220 acts as a tumor suppressor gene by regulating miR-197-5p\/CDH19 in triple-negative breast cancer. Ann Transl Med. 2021;9(15):1236. https:\/\/doi.org\/10.21037\/atm-21-2934.","journal-title":"Ann Transl Med"},{"key":"682_CR64","doi-asserted-by":"publisher","unstructured":"Zhang W, Dai J, Hou G, Liu H, Zheng S, Wang X et al. SMURF2 predisposes cancer cell toward ferroptosis in GPX4-independent manners by promoting GSTP1 degradation. Mol Cell. (2023);83(23):4352\u2013e698. https:\/\/doi.org\/10.1016\/j.molcel.2023.10.042","DOI":"10.1016\/j.molcel.2023.10.042"},{"issue":"1","key":"682_CR65","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12935-023-02946-2","volume":"23","author":"X Yan","year":"2023","unstructured":"Yan X, Liu Y, Li C, Mao X, Xu T, Hu Z, et al. Pien-Tze-Huang prevents hepatocellular carcinoma by inducing ferroptosis via inhibiting SLC7A11-GSH-GPX4 axis. Cancer Cell Int. 2023;23(1):109. https:\/\/doi.org\/10.1186\/s12935-023-02946-2.","journal-title":"Cancer Cell Int"},{"issue":"1","key":"682_CR66","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s12974-022-02400-6","volume":"19","author":"R Dang","year":"2022","unstructured":"Dang R, Wang M, Li X, Wang H, Liu L, Wu Q, et al. Edaravone ameliorates depressive and anxiety-like behaviors via Sirt1\/Nrf2\/HO-1\/Gpx4 pathway. J Neuroinflammation. 2022;19(1):41. https:\/\/doi.org\/10.1186\/s12974-022-02400-6.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"682_CR67","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s13046-019-1413-7","volume":"38","author":"Y Chen","year":"2019","unstructured":"Chen Y, Mi Y, Zhang X, Ma Q, Song Y, Zhang L, et al. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK\/ATF4\/HSPA5 pathway in glioma cells. J Exp Clin Cancer Res. 2019;38(1):402. https:\/\/doi.org\/10.1186\/s13046-019-1413-7.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"682_CR68","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1038\/s41467-021-21841-w","volume":"12","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Swanda RV, Nie L, Liu X, Wang C, Lee H, et al. mTORC1 couples cyst(e)ine availability with GPX4 protein synthesis and ferroptosis regulation. Nat Commun. 2021;12(1):1589. https:\/\/doi.org\/10.1038\/s41467-021-21841-w.","journal-title":"Nat Commun"},{"issue":"3","key":"682_CR69","doi-asserted-by":"publisher","first-page":"188890","DOI":"10.1016\/j.bbcan.2023.188890","volume":"1878","author":"Y Liu","year":"2023","unstructured":"Liu Y, Wan Y, Jiang Y, Zhang L, Cheng W. GPX4: the hub of lipid oxidation, ferroptosis, disease and treatment. Biochim Biophys Acta Rev Cancer. 2023;1878(3):188890. https:\/\/doi.org\/10.1016\/j.bbcan.2023.188890.","journal-title":"Biochim Biophys Acta Rev Cancer"}],"container-title":["Human Genomics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-024-00682-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40246-024-00682-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40246-024-00682-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T15:06:49Z","timestamp":1730819209000},"score":1,"resource":{"primary":{"URL":"https:\/\/humgenomics.biomedcentral.com\/articles\/10.1186\/s40246-024-00682-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1186\/s40246-024-00682-w","relation":{},"ISSN":["1479-7364"],"issn-type":[{"value":"1479-7364","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,5]]},"assertion":[{"value":"14 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No ethical approval is required for this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All authors agree to publish.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"121"}}